Manulife (Manufacturers Life Insurance)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,186	Closed	-$235K	–	3204
2020 Q4	$235K	Buy	+10,186	New	+$129K	﹤0.01%	2677

Manulife (Manufacturers Life Insurance)'s PRVL Position: Q1 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 10,186 shares — an estimated $235K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $235K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Manulife (Manufacturers Life Insurance) reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 10,186 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $235K.
Manulife (Manufacturers Life Insurance) first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Manulife (Manufacturers Life Insurance)'s Prevail Therapeutics Inc. Common Stock position peaked at $235K in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2021, filed 3 May 2021.